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ABSTRACT: Bacterial UDP-N-acetylglucosamine 2-epimerase catalyzes the reversible epimerization at
C-2 of UDP-N-acetylglucosamine (UDP-GlcNAc) and thereby provides bacteria with UDP-N-acetyl-
mannosamine (UDP-ManNAc), the activated donor of ManNAc residues. ManNAc is critical for several
processes in bacteria, including formation of the antiphagocytic capsular polysaccharide of pathogens
such asStreptococcus pneumoniaetypes 19F and 19A. We have determined the X-ray structure (2.5 Å)
of UDP-GlcNAc 2-epimerase with bound UDP and identified a previously unsuspected structural homology
with the enzymes glycogen phosphorylase and T4 phageâ- lucosyltransferase. The relationship to these
phosphoglycosyl transferases is very intriguing in terms of possible similarities in the catalytic mechanisms.
Specifically, this observation is consistent with the proposal that the UDP-GlcNAc 2-epimerase-catalyzed
elimination and re-addition of UDP to the glycal intermediate may proceed through a transition state with
significant oxocarbenium ion-like character. The homodimeric epimerase is composed of two similar
R/â/R sandwich domains with the active site located in the deep cleft at the domain interface. Comparison
of the multiple copies in the asymmetric unit has revealed that the epimerase can undergo a 10° interdomain
rotation that is implicated in the regulatory mechanism. A structure-based sequence alignment has identified
several basic residues in the active site that may be involved in the proton transfer at C-2 or stabilization
of the proposed oxocarbenium ion-like transition state. This insight into the structure of the bacterial
epimerase is applicable to the homologous N-terminal domain of the bifunctional mammalian UDP-
GlcNAc “hydrolyzing” 2-epimerase/ManNAc kinase that catalyzes the rate-determining step in the sialic
acid biosynthetic pathway.
The bacterial UDP-N-acetylglucosamine 2-epimerase
catalyzes the reversible interconversion of UDP-N-acetyl-
glucosamine (UDP-GlcNAc)1 and UDP-N-acetylmannosamine
(UDP-ManNAc) (Scheme 1) (1-4). This enzyme is interest-
ing from a mechanistic perspective because it is able to
catalyze an NAD+-independent epimerization at a stereo-
center that lacks an acidic proton (5, 6). UDP-GlcNAc
2-epimerase, along with UDP-ManNAc dehydrogenase,
provides bacteria with activated forms of both ManNAc and
N-acetylmannosuronic acid (ManNAcUA) residues for use
in the biosynthesis of cell surface polysaccharides (2).
ManNAc residues are found as components of the anti-
phagocytic capsular polysaccharide in pathogenic strains of
bacteria such asStreptococcus pneumoniaetypes 19F and
19A (7, 8). These capsules are responsible for the virulence
of these strains since they coat the bacteria and mask them
from the immune system of the host. ManNAc residues are
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also found in the “linkage unit” that serves to attach teichoic
acids to the peptidoglycan in Gram-positive bacteria (9, 10).
ManNAcUA residues are found as components of the
enterobacterial common antigen (ECA), a surface antigen
found in all enteric or “gut bacteria” (11, 12).
The bacterial epimerase is also of interest due to its
relationship with the bifunctional mammalian UDP-GlcNAc
“hydrolyzing” 2-epimerase/ManNAc kinase (13, 14). This
enzyme catalyzes the irreversible formation of free ManNAc
and UDP from UDP-GlcNAc via an epimerization at C-2
combined with hydrolysis of the glycosidic bond. It also
catalyzes the phosphorylation of ManNAc to generate
ManNAc 6-phosphate. ManNAc 6-phosphate is the direct
precursor toN-acetylneuraminic acid and its derivatives, the
sialic acids. The sialic acids are found at the termini of oligo-
saccharides in a large variety of cell surface glycoconjugates
and are key mediators of cell-cell recognition events (15,
16). They play important roles in a variety of processes,
including microbial infectivity (17), T and B cell activation
(18), and tumorigenicity (19). Recently, it has been found
that the UDP-GlcNAc hydrolyzing 2-epimerase catalyzes
the rate-determining step in the sialic acid biosynthetic
pathway and thus serves as a regulator of cell surface
sialylation (20). The first 380 residues of the 722-residue
mammalian enzyme and the sequence of the full-length
Escherichia coliepimerase are 22% identical (21), indicating
that there is an evolutionary link between the two enzymes
and a structural analysis of one is pertinent to an understand-
ing of the other.
The mechanism of the bacterial epimerase is unique among
sugar nucleotide epimerases in that it involves the elimination
and re-addition of UDP (3, 4). An initial anti elimination
of UDP from UDP-GlcNAc generates the intermediate
2-acetamidoglucal (Scheme 1). A subsequentsyn addition
of UDP gives the product UDP-ManNAc. These steps
presumably occur either in an E1 fashion with discrete
oxocarbenium ion intermediates or via “E1-like E2” transi-
tion states with considerable oxocarbenium ion-like character
(see the lower left inset in Scheme 1) (4, 5). Evidence
supporting a mechanism in which the proton is removed from
C-2 includes the observation that a solvent-derived deuterium
is incorporated at C-2 during catalysis and that the epimer-
ization of UDP-[2-2H]GlcNAc is slowed by a primary kinetic
isotope effect (3, 4, 22). The formation of UDP as an
enzyme-bound intermediate is also supported by the results
of a positional isotope exchange (PIX) experiment. When
UDP-GlcNAc containing an18O label at the anomeric
position was incubated with the epimerase, the label was
seen to scramble from the bridging (anomeric) position into
the nonbridging phosphate positions in a statistical manner.
Finally, the direct detection of the intermediates UDP and
2-acetamidoglucal was possible since the enzyme occasion-
ally releases them into solution. In addition, they are more
thermodynamically stable than the sugar nucleotides and can
therefore be quantitatively generated during extended incuba-
tions. The mechanism of the mammalian UDP-GlcNAc
hydrolyzing 2-epimerase is likely analogous to that of the
bacterial enzyme and involves an ti elimination of UDP
followed by hydration of the resulting 2-acetamidoglucal
intermediate to give ManNAc. The reaction is known to
proceed with the incorporation of a solvent-derived proton
into the C-2 position of ManNAc (23), and follows an
ordered reaction mechanism with UDP released first followed
by the irreversible formation of ManNAc (24). In addition,
it appears the enzyme will accept the glycal intermediate
from solution and hydrate it to form free ManNAc.
To gain further insight into the mechanism of UDP-
GlcNAc 2-epimerase, we have determined the 2.5 Å resolu-
tion structure of the selenomethionine-substituted (SeMet)
enzyme fromE. coli by multiple-wavelength anomalous
dispersion (MAD) phasing. The most intriguing insight
provided by this structure is recognition of the unanticipated
structural homology between UDP-GlcNAc 2-epimerase and
two enzymes that catalyze phosphoglycosyl transfer, glyco-
gen phosphorylase (GP) and T4 phageâ-glucosyltransferase
(BGT). This observation has important repercussions for the
mechanism of UDP-GlcNAc 2-epimerase and may provide
valuable insight into the mechanism of GP for which
mechanistic ambiguities remain (25).
1 Abbreviations: UDP, uridine-5′-diphosphoglucose; GlcNAc,N-
acetylglucosamine; ManNAc,N-acetylmannosamine; NAD+, oxidized
nicotinamide adenine dinucleotide; ManNAcUA, N-acetylmannosuronic
acid; Neu5Ac,N-acetylneuraminic acid; CMP, cytosine 5′-monophos-
phate; GP, glycogen phosphorylase; BGT, T4 phageâ-glucosyltrans-
ferase; SeMet, selenomethionine; MAD, multiwavelength anomalous
dispersion.
Scheme 1: Mechanism of the Reaction Catalyzed by
UDP-GlcNAc 2-Epimerasea
a The inset at the lower left shows the postulated transition state for
the epimeraseanti elimination. The inset at the lower right shows the
postulated transition states for the phosphorylase (first step) and
transferase substitutions.
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MATERIALS AND METHODS
Purification and Crystallization. SeMet UDP-GlcNAc
2-epimerase was expressed according to the procedure of
Ramakrishnan (26) [V. Ramakrishnan and V. Graziano
(http://snowbird.med.utah.edu/∼ramak/madms.html)]. The
SeMet enzyme was purified as previously reported (4) with
an additional step of chromatography. Partially purified UDP-
GlcNAc 2-epimerase was applied to a column of ceramic
hydroxyapatite (Bio-Rad) in 1 mM magnesium chloride
containing 10% glycerol and 2 mM dithiothreitol. The
column was eluted with a linear gradient of 0 to 200 mM
sodium phosphate (pH 6.8) in the loading buffer. To
crystallize SeMet UDP-GlcNAc 2-epimerase, hanging drops
were constructed by mixing the protein solution (4 mg/mL
protein and 2 mM dithiothreitiol) with an equal volume of
mother liquor [13% polyethylene glycol 8000, 0.3 M sodium
chloride, and 0.1 M sodium citrate (pH 5.25)] and 10 vol %
of 0.1 M UDP-GlcNAc. Drops were equilibrated for 24 h at
room temperature before microseeding with crushed crystals
grown from a higher precipitant concentration. Crystals were
visible within 2-7 days and continued to grow for up to
4-6 weeks. All crystals belonged to space groupP21 with
the following unit cell dimensions:a ) 89.5 Å, b ) 94.0
Å, c ) 100.8 Å, andâ ) 109.6°. A Matthews coefficient of
2.4 Å3/Da is consistent with the two dimers of UDP-GlcNAc
2-epimerase observed in the asymmetric unit. Crystals could
be grown to dimensions in the range of 0.3 mm, though
smaller crystals (e0.1 mm) tended to have lower mosaicity.
The wild-type UDP-GlcNAc 2-epimerase suffered from
prohibitively poor mosaicity, and satisfactory crystals could
not be obtained.
Data Collection and Processing. Prior to data collection,
crystals were transferred to a cryoprotectant solution of
mother liquor containing 25% glycerol before being flash-
cooled in a stream of N2 (100 K). Diffraction data to 2.5 Å
for the MAD experiment with the SeMet UDP-GlcNAc
2-epimerase crystals were collected using a Brandeis Q4
CCD detector mounted at beamline X12C (Brookhaven
National Laboratory, Upton, NY). Three data sets (Table 1)
were collected on a single crystal at wavelengths corre-
sponding to the selenium absorption edge (λ ) 0.9790 Å),
the peak (λ2 ) 0.9787 Å), and a wavelength remote from
the selenium absorption edge (λ3 ) 0.9400 Å). All diffraction
data were processed with DENZO/SCALEPACK (27), and
selenium atom positions were determined using data to 2.8
Å in SOLVE (28) which was successful in identifying 37 of
the 40 selenium atoms per asymmetric unit.
Model Building and Structural Refinement. Solvent flat-
tening using DM (29) produced a readily interpretable
electron density map with well-defined density for 1298 of
the 1504 amino acids expected in the asymmetric unit.
Noncrystallographic symmetry averaging (DM) provided
only moderate improvements in the electron density. Model
building was carried out with XTALVIEW (30), and all
refinement was performed in CNS-XPLOR (31). An initial
model was built against the most complete monomer and
the N- and C-terminal domains individually used for rigid
body minimization against the other three monomers.
Structural refinement proceeded with multiple cycles of
simulated annealing and restrainedB-factor refinement
against the remote data set in CNS-XPLOR. Strict NCS
restraints were used in early rounds of refinement but were
gradually relaxed and entirely removed by the final round.
The refined structure of SeMet UDP-GlcNAc 2-epimerase
contained 1489 amino acids, 765 water molecules, 4 UDP
molecules, 4 sodium ions, and 4 chloride ions. The model
was evaluated with the program PROCHECK (32) and is
better than average in all statistical indicators of model
quality.
Analysis of Protein Structure. The primary sequence
alignment included 29 sequences of UDP-GlcNAc 2-epimer-
ase from both bacterial and mammalian sources that were
retrieved from the SWISS-PROT database. The initial align-
ment was performed with the program CLUSTALW (33)
and then manipulated to maximize conservation of secondary
structural elements as identified by PROMOTIF (34). Struc-
tural alignment with BGT and GP (PDB entries 1QKJ and
3GPB) was based on visual inspection ofR-carbon super-
positions that were performed using the LSQ commands (3.8
Å cutoff) in the program O (35). Automated analysis of the
dimer interface was performed with the protein-protein
interaction server of S. Jones and J. M. Thornton (http://
www.biochem.ucl.ac.uk/bsm/PP/server). All depictions of
UDP-GlcNAc 2-epimerase were created with MOLSCRIPT
(36).
RESULTS
Tertiary Structure. Bacterial UDP-GlcNAc 2-epimerase
is composed of twoR/â/R domains that form a deep cleft at
the domain interface. A ribbon representation of the overall
fold of the enzyme is shown in Figure 1a with secondary
structural elements numbered sequentially. The N-terminal
domain (residues 1-170 and 360-371) consists of a seven-
stranded parallelâ-sheet (â1-â7) that is sandwiched between
a total of sevenR-helices (R1-R6 andR16) with a topology
that is similar to the Rossmann dinucleotide binding fold
(37). The final strand (â7) of the N-terminal domain leads
into a region of twoR-helices (residues 171-205, R7 and
Table 1: Data Collection, Phasing, and Refinement Statistics
Data Collection
λ1 λ2 λ3
wavelength (Å) 0.9790 0.9787 0.9400
resolution range (Å) 30-2.50 30-2.50 30-2.50
no. of observationsa 172475 (7101) 172602 (7007) 163518 (6804)
no. of unique reflcns 51549 (2404) 51929 (2459) 50792 (2386)
completeness (%) 94.7 (89.9) 95.5 (91.8) 93.1 (89.0)
Rmerge(%) 4.9 (29.3) 6.8 (31.7) 5.1 (20.9)
I/σ 26.7 (3.6) 18.5 (2.6) 21.6 (3.6)
Phasing Statisticsb Refinement Statisticsc
resolution range (Å) 30-2.8 resolution range (Å) 30-2.5
no. of reflections 37198 no. of reflections 49090
no. of Se sites 37 Rfactor (%) 19.8
occupancy range 0.24-1.0 Rfree (test set, %)d 27.1
B-factor range (Å2) 15-60 rmsd for bonds (Å) 0.009
figure of merit 0.68 (0.43) rmsd for angles (deg) 1.3
overallB-factor (Å2) 35.8
a Values in parentheses refer to the highest-resolution shell which
is 2.54-2.50 Å for data collection and 2.80-2.89 Å for phasing.
b Results from SOLVE were improved when the highest-resolution data
was excluded.c The model was refined against the remote (λ3) SeMet
data set.d Rfree was calculated on 10% of the reflections randomly
omitted from the refinement.
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R8) that serves to link the two domains. The C-terminal
domain (residues 206-359) contains a six-strandedâ-sheet
(â8-â13) that also has the topology of the Rossmann
dinucleotide binding fold and is surrounded by a total of
FIGURE 1: Overall structure of UDP-GlcNAc 2-epimerase. (a) Ribbon representation of the closed chain monomer of UDP-GlcNAc
2-epimerase with bound UDP shown as a ball-and-stick representation. The monomer is composed of two similarR/â/R domains that are
colored in purple and yellow for the N-terminal domain and red and blue for the C-terminal domain. The strictly conserved Gly170 (green
coil) may be a critical component of the interdomain hinge. No density was observed for residues 61-63 of this chain, and thus, there is
a break betweenâ3 andR3. (b) The dimer of UDP-GlcNAc 2-epimerase is composed of one open chain and one closed chain that differ
by an approximate 10° rigid body rotation between the two domains. The closed chain is colored as described for panel a. (c) Overlap of
the C-R atoms of the open (gray) and closed (red) chains of the UDP-GlcNAc 2-epimerase dimer highlighting the interdomain rotation. The
N-terminal domain in the open and closed forms has been superimposed in this figure.
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seven R-helices (R9-R15). The C-terminal end of the
C-terminal domain finds the polypeptide chain (residues
356-361) back at the domain interface where it crosses over
the interdomain linker at residue 170. Following this
crossover isR16 that is packed against theâ-sheet core of
the N-terminal domain and leads to the C-terminus that is
approximately 10 Å from the N-terminus. In each of the four
monomers in the asymmetric unit, a sodium ion (B-factor
range of 17-37 Å2) coordinated by the main chain carbonyls
of Pro298, Ser350, and Ala352 was apparent. The sodium
ion is distant from the active site, but is located at the
C-terminal end ofR12, the helix that forms several critical
interactions with the UDP moiety of the substrate. A role
for sodium in the structural stabilization of UDP-GlcNAc
2-epimerase correlates with a previous report that monovalent
metal ions, such as sodium, increase the epimerase activity
of the mammalian enzyme (38).
A search of the Protein Data Bank with the program DALI
(39) revealed that the proteins with the greatest degree of
structural homology with UDP-GlcNAc 2-epimerase are T4
phageâ-glucosyltransferase (BGT) (40, 41) and the core
domains of glycogen phosphorylase (GP). The conservation
of three-dimensional structure between BGT and GP has been
previously recognized and discussed in some detail (42, 43).
An R-carbon superposition of UDP-GlcNAc 2-epimerase
with each of these two enzymes gave a rms deviation of
2.4 Å over 129 and 162 atoms for BGT (Figure 2b) and
GP, respectively. When the two domains of UDP-GlcNAc
2-epimerase were treated individually to account for slight
changes in domain orientation, the overlap improved in
both cases to give a rms deviation of 2.0 Å over 151 and
209 atoms, respectively. With the exceptions ofR2 and
R8, for every secondary structural element of UDP-
GlcNAc 2-epimerase, an analogous element is conserved in
BGT, GP, or both. This structural conservation is remarkable
when one considers that the degree of sequence identity
between UDP-GlcNAc 2-epimerase and each of these two
enzymes is less than 10%. Figure 2a shows a structure-
based sequence alignment of UDP-GlcNAc 2-epimerase with
BGT and GP.
ConserVed Residues. A structure-guided sequence align-
ment of UDP-GlcNAc 2-epimerase (Figure 2a shows 4 of
the 29 sequences) revealed 10 strictly conserved residues.
Six additional positions exhibit conservation of Glu and/or
Asp (Glu12, Glu117, Glu131, Glu132, and Asp175) or Lys
and/or Arg (Lys15) in at least 27 of the 29 sequences. Five
of these 16 residues can be tentatively assigned a role in
stabilization of the tertiary structure (Glu12, Gly94, His115,
Gly119, and Glu132). Two residues (Gly170 and Asp175)
are found at the interdomain hinge region and are probably
involved in facilitating the interdomain rotation. Three
residues (Arg10, Ser290, and Glu296) have been confidently
assigned a role in binding the UDP portion of the substrate
and will be discussed below. The remaining six residues
(Lys15, Asp95, Glu117, Glu131, Arg135, and His213) are
all found in the vicinity of the active site, close to where the
GlcNAc portion of UDP-GlcNAc is expected to bind. While
it would be premature to speculate about possible catalytic
roles (if any) for the majority of these active site residues,
His213 will be discussed below as a possible general acid
catalyst. It is also worth noting that a proposed catalytic base
of BGT (Glu22) does align with active site Lys15 of UDP-
GlcNAc 2-epimerase (41). The only published mutagenesis
study of UDP-GlcNAc 2-epimerase reportedly identified
several histidine residues (including His115) as being
important for the catalytic activity and the oligomeric
structure of the mammalian enzyme (21). Unfortunately, that
study neglected to investigate the role of His213, the only
conserved histidine residue that is probably involved in the
catalytic mechanism.
Quaternary Structure. The asymmetric unit of the crystals
of UDP-GlcNAc 2-epimerase contains four copies of the
enzyme arranged as two similar copies of the biological
homodimer (2). As shown in panels b and c of Figure 1,
each dimer is composed of one open and one closed
monomer that differ by an approximately 10° interdomain
rotation. The domains appear to rotate as rigid bodies about
the hinge region (residues 169-172 and 356-361) at the
domain interface on the backside of the enzyme when
oriented as in Figure 1a. The strictly conserved Gly170
(green coil in Figure 1a) appears to be critical for the
flexibility of this hinge region. The majority of the 1500 Å2
dimer interface is composed of the threeR-helices (R3-
R5). The dimer interface of UDP-GlcNAc 2-epimerase is
predominantly hydrophobic and stabilized by nine hydrogen
bonds (44). On the periphery of the dimer interface are two
intersubunit salt bridges (Glu69-Lys79 and the noncrystal-
lographic counterpart) and a potential intersubunit disulfide
bridge (Cys72-Cys72) that could contribute to stabilization
of the dimer. Although the thiols of Cys72 of adjacent
subunits are within 4 Å of each other,Fo - Fc difference
density maps provide no evidence of disulfide bridges,
possibly due to the inclusion of a reducing agent in the
crystallization solution. It is interesting to note that the
secondary structural elements that contribute the most to the
dimer interface (R3 and R4) are not conserved in the
monomeric BGT (see Figure 2a,b). The intersubunit contacts
of dimeric GP occur through regions of the protein that are
not present in UDP-GlcNAc 2-epimerase (45).
Substrate Binding. In the deep interdomain cleft of the
closed chains of UDP-GlcNAc 2-epimerase, density corre-
sponding to a well-ordered molecule of UDP (Bav ) 13
and 21 Å2 in the two closed chains) is visible, identifying
this region as the active site. The active site of the open
chain dimer partner also contains density consistent with the
uridine moiety; however, there is only very weak difference
density in the region where the pyrophosphate moiety of
UDP is expected to reside. Efforts to explain this difference
density by invoking multiple conformations of the pyro-
phosphate group were unsatisfactory, and thus in the open
chains, UDP has been fixed in a conformation similar to
that observed in the closed chains. The observation of UDP,
as opposed to UDP-GlcNAc, in the active site is not
surprising since prolonged incubation of substrate with UDP-
GlcNAc 2-epimerase results in quantitative formation of
the thermodynamically favored intermediates, UDP and
2-acetamidoglucal (3, 4). Active site difference density
proximal to theâ-phosphate of UDP in the closed chain was
explained with several water molecules that behaved well
during the refinement. Attempts to model all the active site
density either as UDP-GlcNAc or as both the bound
intermediates, UDP and 2-acetamidoglucal, were unsuccess-
ful. The R-carbon superpositions indicate that the position
Accelerated Publications Biochemistry, Vol. 39, No. 49, 200014997
and orientation of the bound UDP are very similar to those
observed for UDP in BGT and pyridoxal 5′-phosphate in
GP, providing another convincing link between these three
enzymes.
FIGURE 2: (a) Representative sequence alignment of 29 sequences of UDP-GlcNAc 2-epimerase. AllR-helix andâ-strand structures are
numbered sequentially as in Figure 1a and indicated by black boxes. Positions in the sequence highlighted with white text on green are
strictly conserved, while positions highlighted in black on yellow exhibit strong conservation. The structure-based alignments with GP and
BGT are based uponR-carbon superpositions performed in the program O. Residues of either GP or BGT mentioned in the text are in bold.
Only those residues of GP identified as being structurally equivalent to residues of UDP-GlcNAc 2-epimerase are shown, and consequently,
some secondary structural elements are truncated. Labeling of the secondary structural elements of GP and BGT is consistent with the
literature conventions. (b) C-R superposition of BGT with UDP-GlcNAc 2-epimerase. The two domains of each molecule were superimposed
individually to account for slight changes in domain rotation between the two structures.
14998 Biochemistry, Vol. 39, No. 49, 2000 Accelerated Publications
In Figure 3a, the hydrogen bonds involved in binding of
the UDP moiety are illustrated. In the closed chain, further
stabilization of the bound UDP results fromπ-stacking of
the uracil ring between the phenyl of Phe276 and the
guanidinium of Arg10. Arg10 also forms a hydrogen bond
with the ribose ring oxygen (2.7 Å) and is within 3.6 Å of
the R-phosphate of UDP. In addition to the hydrogen bond
with Arg10, the ribose of UDP forms two hydrogen bonds
(2.7 and 2.9 Å) between the ribose hydroxyls and the
carboxylate of Glu296. The critical interactions for binding
of the pyrophosphate group are hydrogen bonds with the
hydroxyl of Ser290 (2.9 and 3.2 Å) and the main chain
amides of Gly291 (2.8 Å) and Gly292 (3.3 Å) which are
found at the N-terminus ofR12. His213 also contributes to
stabilization of the pyrophosphate group, but as this inter-
action may be relevant to the catalytic mechanism, it will
be further discussed below. The most important differ-
ences in the protein-UDP interactions between the open
and closed chains are shown in Figure 3b. In the open chain,
the 10° interdomain rotation shifts the N-terminus ofR12
approximately 3-4 Å away from its position in the closed
chain, drawing Glu296 back from the ribose ring and
disrupting the majority of the possible hydrogen bonds with
UDP. As will be discussed, this conformational change is
probably associated with the regulatory mechanism of UDP-
GlcNAc 2-epimerase.
DISCUSSION
Despite its widespread distribution in organisms ranging
from bacteria to mammals, GP had no known structural
analogues prior to the publication of the structure of BGT
(40). The observed structural homology between BGT and
GP prompted some initial speculation about their evolution-
ary relationship and the suggestion that they are probably
the first two members of a glycosyltransferase superfamily
that shares a distinctive core structure (38, 39). Interestingly,
the work reported here shows that the third member of the
GP and BGT superfamily is UDP-GlcNAc 2-epimerase, an
enzyme that catalyzes the reversible interconversion of
UDP-GlcNAc and UDP-ManNAc. This apparent incongruity
is explained when one considers that as with a glycosyl-
transferase, the epimerization mechanism proceeds via the
cleavage of a phosphoglycosyl bond, albeit in an elimination
event as opposed to a substitution.
A unique aspect of the bacterial epimerase is the strict
regulatory role played by the substrate UDP-GlcNAc which
FIGURE 3: (a) Hydrogen bonds (angstroms) involved in binding the UDP portion of the substrate. The density corresponds to anFo - Fc
omit map contoured at 3σ calculated with the final coordinates minus UDP. (b) Superposition of the active sites of both the open and closed
chains such that overlap of the uridine groups is maximized. Residues from the closed chain (blue) are represented with colored atoms,
while residues from the open chain (gray) are represented with white atoms.
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is required for activity (half-maximal activation occurs at
approximately 0.6 mM) (1, 2, 4). This is most readily
observed in the sigmoidal dependence of the reaction rate
on the UDP-GlcNAc concentration (Hill coefficient of 2.0)
and on the inability of the enzyme to epimerize pure UDP-
ManNAc in the absence of UDP-GlcNAc. Our structure
shows that each subunit of the homodimeric bacterial UDP-
GlcNAc 2-epimerase has a single UDP-GlcNAc binding site,
and consequently, allosteric activation through binding to a
second regulatory site on the enzyme can be ruled out. The
best explanation of the regulatory mechanism is that binding
of UDP-GlcNAc to one subunit induces a conformational
change across the dimer interface that converts the dimer
partner to the catalytically active form. The two forms of
UDP-GlcNAc 2-epimerase observed in the X-ray structure
differ by a 10° interdomain rotation and several local
conformational changes. The interdomain rotation is remi-
niscent of the well-studied transition between the inactive T
state and the active R state of GP (46) and the conformational
change that occurs upon substrate binding in BGT (40).
Among the most intriguing differences between the open and
closed chains is the movement of the flexible loop region
betweenâ8 andR9 (residues 211-218) that contains the
strictly conserved His213 (Figure 3b). In the closed chain,
the imidazole ring of His213 forms a hydrogen bond (2.9
Å) with the â-phosphate of UDP. In the open chain, the
Thr211-Phe218 loop has swung out of the active site,
placing the imidazole ring of His213 more than 7 Å away
from theâ-phosphate. His213 of the closed chain is the only
residue that forms a hydrogen bond with theâ-phosphate of
UDP and could act as a general acid catalyst to activate the
UDP of the substrate for elimination. On the basis of this
proposal, it is probable that the closed chain of UDP-GlcNAc
2-epimerase is the active subunit and the open chain is the
regulatory subunit of the homodimer.
Although UDP-GlcNAc 2-epimerase shares a common
overall structure with BGT and the core domains of GP, these
three enzymes do not share any conserved catalytic residues.
The only residue that is strictly conserved through all
sequences of UDP-GlcNAc 2-epimerase and is found in
either BGT or GP is Glu296 that aligns with Glu272 of BGT.
As in UDP-GlcNAc 2-epimerase, Glu272 of BGT forms
hydrogen bonds with the ribose hydroxyls of its substrate,
UDP-glucose (40). As previously noted, this position also
aligns with Lys680 of GP that forms a Schiff base linkage
with the pyridoxal 5′-phosphate coenzyme (42, 43). The
structure-based alignment with BGT and GP also revealed
that His213 aligns with Ser189 of BGT and Arg569 of GP,
two residues that have been implicated in binding the
phosphate groups of their respective substrates (40, 46). In
the transition of GP from the inactive T state to the active R
state, Arg569 undergoes a conformational change that results
in formation of the phosphate recognition site for glucose
1-phosphate (46). As discussed above, His213 undergoes an
analogous conformational change during the 10° interdomain
rotation and adopts a position in which it can act as a general
acid catalyst only in the closed chain.
The detailed mechanism by which UDP-GlcNAc 2-epimer-
ase catalyzes both thesyn and anti elimination of UDP is
unknown. It has been suggested that the elimination
occurs by either an E1 or an “E1-like E2” mechanism with
significant oxocarbenium ion-like character in the transition
state (see the lower left inset in Scheme 1) (4, 5). On the
basis of this structure, active site residues that likely play
key roles in promoting the elimination steps include Asp95,
Glu117, and Glu131. They may serve as the acid or base
residues involved in proton transfer at C-2 or serve to
stabilize an oxocarbenium ion-like transition state via
electrostatic catalysis. In addition, His213 is a good candidate
for acting as a general acid that protonates the departing
UDP. The observation that UDP-GlcNAc 2-epimerase shares
a common overall fold with GP and BGT suggests a distant
evolutionary relationship exists between these two enzymes.
A possible mechanistic link is further supported by experi-
mental evidence for an oxocarbenium ion-like transition state
in GP (see the lower right inset in Scheme 1) (25, 47). During
the final revision of the manuscript, a paper appeared
describing the structure of a GlcNAc transferase, MurG,
involved in peptidoglcan biosynthesis (48). Superposition of
epimerase with MurG shows a marked similarity, suggesting
it also evolved from a common ancestor (rms deviation of
2.3 Å for 157 common C-R atoms or, if the two domains in
each molecule are superposed individually, an rms deviation
of 2.0 Å on 225 common C-R atoms). This notion is
particularly appealing since both MurG and the epimerase
utilize UDP-GlcNAc as a substrate. It is tempting to speculate
that although the primary sequence and catalytic specificity
of UDP-GlcNAc 2-epimerase has drastically diverged
from that of GP, BGT, and MurG, the ability to stabilize
a transition state with oxocarbenium ion character has
persisted.
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